BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:8c3a5437dab0ccf76e109b5251e65375
DTSTAMP:20260603T231057Z

DTSTART:20200616T130000
DTEND:20200616T150000
SUMMARY:ECI Webinar: Virtual Vaccine Technology: Focus on Covid-19
DESCRIPTION:Please join us for a free webinar,&nbsp;Virtual Vaccine Technology: Focus on Covid-19, scheduled for Tuesday, June 16, 2020, from 1 – 3 pm (Central Europe Time) 7 – 9 am (US Eastern Standard time).&nbsp;You are receiving this invitation as you have previously attended one of ECI’s&nbsp;Vaccine Technology,&nbsp;Cell Culture,&nbsp;or&nbsp;Biochemical and Molecular Engineering&nbsp;conferences or have asked to be on our mailing list.\nSpace is limited and we urge you to register as soon as possible at the following link:&nbsp;Click Here.&nbsp;&nbsp;\n\nPlease disregard if you have already signed up for this webinar.\n\nOn June 15 you will receive the link to join the virtual webinar.&nbsp; The link is for your use only.&nbsp; Each speaker will talk for approximately ten minutes and five minutes will be reserved for questions.\nThe Program:\n1:00 – 1:05&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Introduction by&nbsp;Vaccine Technology VIII&nbsp;Chairs\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Francesc Gòdia, Charles Lutsch, Linda Hwee-Lin Lua, Tarit Mukhopadhyay&nbsp;\n1:05 – 1:20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Julià Blanco\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; IRSI Caixa, Barcelona, Spain\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Characteristics and mechanisms of action of SARS CoV-2: What do we know?”\n1:20 – 1:35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Silvie Briand\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; WHO, Geneva, Switzerland\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Covid-19: an unprecedented pandemic”&nbsp;\n1:35 – 1:50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jerome Kim\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; International Vaccine Institute, Seoul, South Korea\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Test, track, isolate, and treat in South Korea”&nbsp;\n1:50 – 2:05&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jim Robinson\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CEPI (Coalition for Epidemic Preparedness Innovations), Oslo, Norway\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Considerations for Manufacturing for a &nbsp;Pandemic”&nbsp;\n2:05 – 2:20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paul Young\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; University of Queensland, Brisbane, Australia\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Molecular Clamp Technology for Covid-19 vaccines”&nbsp;\n2:20 – 2:35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Valérie Lecouturier\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Sanofi Pasteur, Marcy l’Etoile, France\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Development of a subunit Covid-19 pandemic vaccine”&nbsp;\n2:35 – 2:50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;David Robinson\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Bill and Melinda Gates Foundation, Seattle, USA\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Global response to current and future pandemics”&nbsp;\n2:50 – 3:00&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recap and Future –&nbsp;Vaccine Technology VIII&nbsp;Conference Chairs&nbsp;\nVaccine Technology VIII has rescheduled for March 14-19, 2021 at the Melia Hotel in Sitges, Spain.&nbsp; For&nbsp;more information.&nbsp;\nEngineering Conferences International (ECI) is a not-for-profit global engineering conferences program, originally established in 1962, that provides for the exploration of problems and issues of concern to engineers and scientists from many disciplines.

X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">\n<HTML>\n<HEAD>\n<META NAME="Generator" CONTENT="MS Exchange Server version 08.00.0681.000">\n<TITLE></TITLE>\n</HEAD>\n<BODY>\n<!-- Converted from text/rtf format -->\n\n<p>Please join us for a free webinar,&nbsp;<strong>Virtual Vaccine Technology: Focus on Covid-19</strong>, scheduled for Tuesday, June 16, 2020, from 1 – 3 pm (Central Europe Time) 7 – 9 am (US Eastern Standard time).&nbsp;You are receiving this invitation as you have previously attended one of ECI’s&nbsp;<strong>Vaccine Technology</strong>,&nbsp;<strong>Cell Culture,</strong>&nbsp;or&nbsp;<strong>Biochemical and Molecular Engineering</strong>&nbsp;conferences or have asked to be on our mailing list.</p><br /><p>Space is limited and we urge you to register as soon as possible at the following link:&nbsp;<a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0ODk/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">Click Here</a>.&nbsp;&nbsp;<br /><br /><em><b>Please disregard if you have already signed up for this webinar.</b></em><br /><br />On June 15 you will receive the link to join the virtual webinar.&nbsp; The link is for your use only.&nbsp; Each speaker will talk for approximately ten minutes and five minutes will be reserved for questions.</p><br /><p>The Program:</p><br /><p>1:00 – 1:05&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Introduction by&nbsp;<strong>Vaccine Technology VIII</strong>&nbsp;Chairs<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Francesc Gòdia, Charles Lutsch, Linda Hwee-Lin Lua, Tarit Mukhopadhyay&nbsp;</p><br /><p>1:05 – 1:20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTA/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">Julià Blanco</a></strong><b><br /></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; IRSI Caixa, Barcelona, Spain<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Characteristics and mechanisms of action of SARS CoV-2: What do we know?”</p><br /><p>1:20 – 1:35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTE/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">Silvie Briand</a></strong><b><br /></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; WHO, Geneva, Switzerland<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Covid-19: an unprecedented pandemic”&nbsp;</p><br /><p>1:35 – 1:50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTI/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">Jerome Kim</a></strong><b><br /></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; International Vaccine Institute, Seoul, South Korea<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Test, track, isolate, and treat in South Korea”&nbsp;</p><br /><p>1:50 – 2:05&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTM/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">Jim Robinson</a></strong><b><br /></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CEPI (Coalition for Epidemic Preparedness Innovations), Oslo, Norway<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Considerations for Manufacturing for a &nbsp;Pandemic”&nbsp;</p><br /><p>2:05 – 2:20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTQ/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">Paul Young</a></strong><b><br /></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; University of Queensland, Brisbane, Australia<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Molecular Clamp Technology for Covid-19 vaccines”&nbsp;</p><br /><p>2:20 – 2:35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTU/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">Valérie Lecouturier</a></strong><b><br /><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</strong></b>Sanofi Pasteur, Marcy l’Etoile, France<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Development of a subunit Covid-19 pandemic vaccine”&nbsp;</p><br /><p>2:35 – 2:50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<strong><a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTY/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">David Robinson</a></strong><b><br /></b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Bill and Melinda Gates Foundation, Seattle, USA<br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; “Global response to current and future pandemics”&nbsp;</p><br /><p>2:50 – 3:00&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Recap and Future –&nbsp;<strong>Vaccine Technology VIII</strong>&nbsp;Conference Chairs&nbsp;</p><br /><p>Vaccine Technology VIII has rescheduled for March 14-19, 2021 at the Melia Hotel in Sitges, Spain.&nbsp; For&nbsp;<a href="http://eci.informz.net/z/cjUucD9taT05MzcyNDc1JnA9MSZ1PTExMTcwNDU0MzYmbGk9Nzc1MTY0OTc/index.html" target="_blank" rel="noopener noreferrer" data-auth="NotApplicable">more information</a>.&nbsp;</p><br /><p>Engineering Conferences International (ECI) is a not-for-profit global engineering conferences program, originally established in 1962, that provides for the exploration of problems and issues of concern to engineers and scientists from many disciplines.</p>\n\n</BODY>\n</HTML>

LOCATION:
END:VEVENT

END:VCALENDAR
